BLUE BLUEBIRD BIO INC revenue, earnings and financials
For the quarter ended March 31, 2025, BLUEBIRD BIO INC reported revenue of $38.7M (up 108.4% from a year earlier), net income of −$29.1M and diluted EPS of −$2.98; over the last four quarters revenue was $104M and net income −$200M; for the fiscal year ended December 2024 revenue was $83.8M, up 184.1% on the year before.
BLUE annual revenue and earnings
- Fiscal year ended Dec 2024: revenue $83.8M, gross profit −$5.57M, operating income −$270M, net income −$241M (margin -287.2%), EPS −$24.84
- Fiscal year ended Dec 2023: revenue $29.5M, gross profit −$4.03M, operating income −$244M, net income −$212M (margin -718.4%), EPS −$38.59
- Fiscal year ended Dec 2022: revenue $3.60M, gross profit −$6.48M, operating income −$250M, net income −$230M (margin -6403.7%), EPS −$2.93
- Fiscal year ended Dec 2021: revenue $3.66M, gross profit n/a, operating income −$591M, net income −$819M (margin -22375.2%), EPS −$11.89
BLUE quarterly revenue and earnings
- Quarter ended Mar 31, 2025: revenue $38.7M (up 108.4% year over year), net income −$29.1M, EPS −$2.98
- Quarter ended Dec 31, 2024 (from the annual report): revenue $38.5M (up 391.7% year over year), net income −$28.7M, EPS −$16.88
- Quarter ended Sep 30, 2024: revenue $10.6M (down 14.4% year over year), net income −$60.8M, EPS −$0.31
- Quarter ended Jun 30, 2024: revenue $16.1M (up 133.7% year over year), net income −$81.4M, EPS −$0.42
- Quarter ended Mar 31, 2024: revenue $18.6M (up 680.1% year over year), net income −$69.8M, EPS −$7.23
- Quarter ended Dec 31, 2023 (from the annual report): revenue $7.83M (up 12535.5% year over year), net income −$80.8M, EPS −$37.39
- Quarter ended Sep 30, 2023: revenue $12.4M (up 17353.5% year over year), net income −$87.2M, EPS −$0.80
- Quarter ended Jun 30, 2023: revenue $6.89M (up 353.6% year over year), net income −$62.8M, EPS −$0.58
- Quarter ended Mar 31, 2023: revenue $2.38M (up 22.4% year over year), net income $18.9M, EPS $0.18
- Quarter ended Dec 31, 2022 (from the annual report): revenue $62.0K (down 96.1% year over year), net income $68.5M, EPS −$0.63
- Quarter ended Sep 30, 2022: revenue $71.0K (down 93.0% year over year), net income −$76.5M, EPS −$0.94
- Quarter ended Jun 30, 2022: revenue $1.52M (up 962.2% year over year), net income −$100M, EPS −$1.36
- Quarter ended Mar 31, 2022: revenue $1.95M (up 117.6% year over year), net income −$122M, EPS $0.00
- Quarter ended Dec 31, 2021: revenue $1.61M, net income −$155M, EPS −$2.14
- Quarter ended Sep 30, 2021: revenue $1.02M, net income −$217M, EPS −$3.16
- Quarter ended Jun 30, 2021: revenue $143K, net income −$242M, EPS −$3.58
- Quarter ended Mar 31, 2021: revenue $894K, net income −$206M, EPS −$3.07
BLUE cash flow, buybacks and dividends
- Fiscal year ended Dec 2024: operating cash flow −$260M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$235M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$316M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$636M, share buybacks n/a
BLUE balance sheet
- Mar 31, 2025: cash $78.7M, total assets $296M, total liabilities $354M, shareholders' equity −$57.9M
- Dec 31, 2024: cash $62.3M, total assets $460M, total liabilities $492M, shareholders' equity −$31.5M
- Sep 30, 2024: cash $70.7M, total assets $465M, total liabilities $471M, shareholders' equity −$5.79M
- Jun 30, 2024: cash $144M, total assets $545M, total liabilities $492M, shareholders' equity $53.0M
- Mar 31, 2024: cash $212M, total assets $631M, total liabilities $500M, shareholders' equity $131M
- Dec 31, 2023: cash $222M, total assets $619M, total liabilities $425M, shareholders' equity $195M
- Sep 30, 2023: cash $165M, total assets $614M, total liabilities $391M, shareholders' equity $153M
- Jun 30, 2023: cash $173M, total assets $663M, total liabilities $374M, shareholders' equity $235M
What is BLUE's revenue?
BLUEBIRD BIO INC reported $104M of revenue over its last four quarters, through March 31, 2025.
Is BLUE profitable?
No. BLUEBIRD BIO INC lost $200M over the last four quarters.
What is BLUE's EPS?
Diluted earnings per share over the last four quarters were −$20.59; −$2.98 in the latest quarter.